| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 62 |
| 1 | METHOTREXATE SODIUM | 54 |
| 2 | TOFACITINIB | 47 |
| 3 | METHOTREXATE | 43 |
| 4 | ETANERCEPT | 42 |
| 5 | ABATACEPT | 30 |
| 6 | TOCILIZUMAB | 29 |
| 7 | RITUXIMAB | 23 |
| 8 | HUMAN IMMUNOGLOBULIN G | 22 |
| 9 | OCRELIZUMAB | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 3 | 0.0025 |
| 1 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 2 | ISRADIPINE | 1 | 0.0018 |
| 3 | PILOCARPINE HYDROCHLORIDE | 4 | 0.0016 |
| 4 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 5 | RITLECITINIB | 3 | 0.0015 |
| 6 | HUMAN IMMUNOGLOBULIN G | 22 | 0.0011 |
| 7 | HYALURONIC ACID | 1 | 0.0009 |
| 8 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| 9 | ENTECAVIR | 9 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 30 | 0.0014 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 6 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 30 | 0.0002 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 30 | 0.0002 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |